At the end of 2015, I asked if you had taken the time to set big, massive goals for your company in 2016.
Unfortunately, when you have a big vision for your company, the limiting factor is often TIME.
Do you have enough time to bring more customers into your pipeline, attract more visitors to your website, and get more followers on social media? As a high-level executive, the answer is likely “no.”
If you are ready to create massive awareness for your stem cell brand, at only a fraction of what it would cost you to do it yourself, view our “Branding Package – Communicating Your Message into the Stem Cell Marketplace.”
Because we commit substantial resources to each client, we are only able to offer these packages to a small handful of clients across the stem cell marketplace. Due to high demand from existing clients, we can only offer them to 1-2 more clients in 2016.
Will you be one of them?
Benefits to your company are:
- Massive exposure for your stem cell brand, across Google search and social media channels
- Major increase in website traffic and a new pipeline of leads/inquiries for your products
- Price of investment is only a small fraction of what a dedicated marketing employee (or Marketing Team) would cost
- Custom content created by BioInformant, a stem cell expert
- Guaranteed results
If a complete branding solution isn’t the right fit for you, then consider investing in “Twitter Account Management.” With just a small investment, you can get a substantial spike in targeted traffic to your website (about 1,000 views/month) and get 100,000 (or more) new impressions for your Twitter content. Again, guaranteed results.
We’re the fastest growing stem cell account on Twitter. You could grow this quickly too.
Have an investor presentation coming up? We always have you covered in the area of stem cell and cord blood market intelligence.
Be great in 2016, and remember, “If you won’t invest in yourself, no one else will.” (Quote by Grant Cardone)
Want to be better informed than your competition? Get future stem cell industry updates.
BioInformant is the only research firm that has served the stem cell sector since it emerged. Our management team comes from a BioInformatics background – the science of collecting and analyzing complex genetic codes – and applies these techniques to the field of market research. BioInformant research has been cited by major news outlets that include the Wall Street Journal, Nature Biotechnology, CBS News, Medical Ethics, and the Center for BioNetworking. Serving Fortune 500 leaders that include GE Healthcare, Pfizer, Goldman Sachs, Becton Dickinson, and Thermo Fisher Scientific, BioInformant is your global leader in stem cell industry data.
Click here to view our global strategic reports for the stem cell and cord blood industry.